BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 23103836)

  • 21. Inhibition of glypican-3 expression via RNA interference influences the growth and invasive ability of the MHCC97-H human hepatocellular carcinoma cell line.
    Ruan J; Liu F; Chen X; Zhao P; Su N; Xie G; Chen J; Zheng D; Luo R
    Int J Mol Med; 2011 Oct; 28(4):497-503. PubMed ID: 21617840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Silibinin inhibits the invasion and migration of renal carcinoma 786-O cells in vitro, inhibits the growth of xenografts in vivo and enhances chemosensitivity to 5-fluorouracil and paclitaxel.
    Chang HR; Chen PN; Yang SF; Sun YS; Wu SW; Hung TW; Lian JD; Chu SC; Hsieh YS
    Mol Carcinog; 2011 Oct; 50(10):811-23. PubMed ID: 21574189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Screening for differential methylation status by CpG island microarray in the hepatocellular carcinoma cell lines].
    Zheng D; Liu BB; Liu YK; Kang XN; Sun L; Guo K; Sun RX; Chen J; Zhao Y
    Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):891-6. PubMed ID: 19173987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BNIPL-2 promotes the invasion and metastasis of human hepatocellular carcinoma cells.
    Xie L; Qin W; Li J; He X; Zhang H; Yao G; Shu H; Yao M; Wan D; Gu J
    Oncol Rep; 2007 Mar; 17(3):605-10. PubMed ID: 17273740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Establishment of hepatocellular carcinoma multidrug resistant monoclone cell line HepG2/mdr1.
    Chen YB; Yan ML; Gong JP; Xia RP; Liu LX; Li N; Lu SC; Zhang JG; Zeng DB; Xie JG; Yang JY; Yan LN
    Chin Med J (Engl); 2007 Apr; 120(8):703-7. PubMed ID: 17517188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interferon alpha inhibits hepatocellular carcinoma growth through inducing apoptosis and interfering with adhesion of tumor endothelial cells.
    Zhang T; Sun HC; Zhou HY; Luo JT; Zhang BL; Wang P; Wang L; Qin LX; Ren N; Ye SL; Li Q; Tang ZY
    Cancer Lett; 2010 Apr; 290(2):204-10. PubMed ID: 19822391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effects of c-met-siRNA on the growth and invasion of hepatocellular carcinoma MHCC97-H cells].
    Xie B; Tang DG; Dong JH
    Zhonghua Gan Zang Bing Za Zhi; 2006 Jul; 14(7):499-504. PubMed ID: 16867270
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97.
    Li Y; Tang ZY; Ye SL; Liu YK; Chen J; Xue Q; Chen J; Gao DM; Bao WH
    World J Gastroenterol; 2001 Oct; 7(5):630-6. PubMed ID: 11819844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of CD147 gene expression via RNA interference reduces tumor cell invasion, tumorigenicity and increases chemosensitivity to cisplatin in laryngeal carcinoma Hep2 cells.
    Zhu C; Pan Y; He B; Wang B; Xu Y; Qu L; Bao Q; Tian F; Wang S
    Oncol Rep; 2011 Feb; 25(2):425-32. PubMed ID: 21165561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Powerful inhibition of in-vivo growth of experimental hepatic cancers by bombesin/gastrin-releasing peptide antagonist RC-3940-II.
    Szepeshazi K; Schally AV; Rick FG; Block NL; Vidaurre I; Halmos G; Szalontay L
    Anticancer Drugs; 2012 Oct; 23(9):906-13. PubMed ID: 22926257
    [TBL] [Abstract][Full Text] [Related]  

  • 31. KAI1 gene suppresses invasion and metastasis of hepatocellular carcinoma MHCC97-H cells in vitro and in animal models.
    Yang JM; Peng ZH; Si SH; Liu WW; Luo YH; Ye ZY
    Liver Int; 2008 Jan; 28(1):132-9. PubMed ID: 18028322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The properties of tumor-initiating cells from a hepatocellular carcinoma patient's primary and recurrent tumor.
    Xu XL; Xing BC; Han HB; Zhao W; Hu MH; Xu ZL; Li JY; Xie Y; Gu J; Wang Y; Zhang ZQ
    Carcinogenesis; 2010 Feb; 31(2):167-74. PubMed ID: 19897602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppression of liver tumor growth and metastasis by adiponectin in nude mice through inhibition of tumor angiogenesis and downregulation of Rho kinase/IFN-inducible protein 10/matrix metalloproteinase 9 signaling.
    Man K; Ng KT; Xu A; Cheng Q; Lo CM; Xiao JW; Sun BS; Lim ZX; Cheung JS; Wu EX; Sun CK; Poon RT; Fan ST
    Clin Cancer Res; 2010 Feb; 16(3):967-77. PubMed ID: 20103676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glycan profiling of gestational choriocarcinoma using a lectin microarray.
    Kobayashi Y; Masuda K; Banno K; Kobayashi N; Umene K; Nogami Y; Tsuji K; Ueki A; Nomura H; Sato K; Tominaga E; Shimizu T; Saya H; Aoki D
    Oncol Rep; 2014 Mar; 31(3):1121-6. PubMed ID: 24424471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of calmodulin antagonist berbaminederivative-EBB on hepatoma in vitro and in vivo.
    Liu J; Qi S; Zhu H; Zhang J; Li Z; Wang T
    Chin Med J (Engl); 2002 May; 115(5):759-62. PubMed ID: 12133551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression analysis of Cdc42 in lung cancer and modulation of its expression by curcumin in lung cancer cell lines.
    Chen QY; Jiao DM; Yao QH; Yan J; Song J; Chen FY; Lu GH; Zhou JY
    Int J Oncol; 2012 May; 40(5):1561-8. PubMed ID: 22266952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Up-regulation of thymidine phosphorylase and anti-angiogenesis by interferon alpha in human hepatocellular carcinoma cell line and xenograft].
    Xiao YS; Zhou J; Tang ZY; Fan J; Wu ZQ; Liu YK; Ye SL; Shen ZZ; Xue Q; Zhao Y
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(45):3205-9. PubMed ID: 16405841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of beta-catenin by hypoxia in hepatocellular carcinoma contributes to enhanced metastatic potential and poor prognosis.
    Liu L; Zhu XD; Wang WQ; Shen Y; Qin Y; Ren ZG; Sun HC; Tang ZY
    Clin Cancer Res; 2010 May; 16(10):2740-50. PubMed ID: 20460486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The upregulation of dihydropyrimidine dehydrogenase in liver is involved in acquired resistance to 5-fluorouracil.
    Li LH; Dong H; Zhao F; Tang J; Chen X; Ding J; Men HT; Luo WX; Du Y; Ge J; Tan BX; Cao D; Liu JY
    Eur J Cancer; 2013 May; 49(7):1752-60. PubMed ID: 23313143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and characterization of a preclinical ovarian carcinoma model to investigate the mechanism of acquired resistance to trastuzumab.
    Luistro LL; Rosinski JA; Bian H; Bishayee S; Rameshwar P; Ponzio NM; Ritland SR
    Int J Oncol; 2012 Aug; 41(2):639-51. PubMed ID: 22580986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.